CAS: 1628317-18-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MI-463 REF: IN-DA00AR6RCAS: 1628317-18-9 | 99% | To inquire | Mon 16 Dec 24 |
 | MI-463 REF: TM-TQ0058CAS: 1628317-18-9 | 100% - 99.28% | 35.00 €~293.00 € | Mon 23 Dec 24 |
 | MI-463 REF: 3D-DQC31718CAS: 1628317-18-9 | Min. 95% | To inquire | Mon 27 Jan 25 |
Ref: IN-DA00AR6R
| 5mg | 231.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
MI-463
CAS:1628317-18-9
MI-463 is a potent and orally bioavailable inhibitor of the menin-mLL interaction (IC50: 15.3 nM).
Formula:
C24H23F3N6S
Purity:
100% - 99.28%
Color and Shape:
Solid
Molecular weight:
484.54
Ref: TM-TQ0058
| 1mg | 35.00 € | ||
| 5mg | 62.00 € | ||
| 10mg | 88.00 € | ||
| 25mg | 155.00 € | ||
| 50mg | 214.00 € | ||
| 100mg | 293.00 € | ||
| 1mL*10mM (DMSO) | 63.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
MI-463
CAS:1628317-18-9
MI-463 is a drug that has been repurposed to treat cancer. It is a fatty …
Formula:
C24H23F3N6S
Purity:
Min. 95%
Molecular weight:
484.54 g/mol
Ref: 3D-DQC31718
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
